University Hospital Hradec Kralove   Report issue

Academic/Hospital Phase 2 Phase 4
Founded: Hradec Králové Czech Republic (1964)

Organization Overview

First Clinical Trial
2009
NCT01088451
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Faculty Hospital Hradec Králové | University Hospital Hradec Kralove | University Hospital Hradec Králové

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Adenocarcinoma (Phase 2)

Dry Socket (Phase 2)

Hemorrhage (Phase 4)

Hyperaldosteronism (Phase 4)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 2)

Osteitis (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 10
  • # of Trial APIs: 12